Aurobindo pharma’s subsidiary, Auro Vaccines LLC, has entered into a definitive agreement to acquire certain business assets from Profectus BioSciences Inc., U.S., a clinical-stage vaccine development company.
Feedback
AUROPHARMA 
Reputation: 29,954 • Nov 29, 2019 1:53 PM
Vote
Comment
Share